Medicare GLP-1 expansion: long-term volume vs pricing
Medicare's new $50/month GLP-1 coverage opens a 20-million senior TAM for weight loss drugs, though panelists debated whether volume gains will outweigh incremental pricing pressure and commoditization.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.